HMSH2 and nm23 expression in sporadic colorectal cancer and its clinical significance

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1995-1998

  Wu, Hong Wei ^a   Gao, Li Dong ^a   Wei, Guang Hui ^a  

^a Yingkou Central Hospital   (China)

Author keywords

hMSH2; Immunohistochemistry; Nm23; Prognosis; Sporadic colorectal cancer

Indexed keywords

EID: 84880402473     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1995     Document Type: Article

References (20)

1. Chen WC, Lin MS, Zhang BF, et al (2007). Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray. World J Gastroenterol, 13, 699-708.
2. Duncop MG, Farrington SM, Nicholl I, et al (2000). Population carrier frequency of hMSH2 and hMLH1 mulation. Br J Cancer, 83, 1643-5.
3. Dursun A, Akyürek N, Günel N, Yamaç D (2002). Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology, 34, 427-32.
4. Gafa R, Maestri I, Matteuzzi M, et al (2000). Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer, 89, 2025-37.
5. Gradia S, Acharya S, Fishel R (1997). The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch. Cell, 91, 995-1005.
6. Gryfe R, Gallinger S (2001). Microsatellite instability, mismatch repair deficiency, and colorectal cancer. Surgery, 130, 17-20.
7. Hsieh P, Yamane K (2008). DNA mismatch repair: molecular mechanism, cancer, and ageing. Mech Ageing Dev, 129, 391-407.
8. Iyer RR, Pluciennik A, Burdett V, Modrich PL (2006). DNA mismatch repair: functions and mechanisms. Chem Rev, 106, 302-20.
9. Kolodner RD, Hall NR, Lipford J, et al (1995). Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlhl mutations. Cancer Res, 55, 242-8.
10. Leone A, Flatow U, Richter KC, et al (1991). Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35.
11. Leone A, McBride OW, Weston A, et al (1991). Somatic allelic deletion of nm23 in human cancer. Cancer Res, 51, 2490-3.
12. Lipkin SM, Wang V, Jacoby R, et al (2000). MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet, 24, 27-35.
13. Loeb LA (1994). Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res, 54, 5059-63.
14. Marsischky GT, Filosi N, Kane MF, Kolodner R (1996). Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev, 10, 407-20.
15. Okada K, Urano T, Goi T, et al (1994). Isolation of human nm23 genomes and analysis of loss heterozygosity in primary colorectal carcinomas using a specific genomic probe. Cancer Res, 54, 3879-82.
16. Overbeek LI, Ligtenberg MJ, Willems RW, et al (2008). Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol, 32, 1246-51.
17. Rhyu MS (1996). Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst, 88, 240-51.
18. Sarasin A, Stary A (1997). Human cancer and DNA repairdeficient diseases. Cancer Detect Prev, 21, 406-11.
19. Steeg PS, Bevilacqua G, Kopper L, et al (1988). Evidence for a novel gene associated with low tumor metastatic potential. J Nat Cancer Inst, 80, 200-4.
20. Suzuki E, Ota T, Tsukuda K, et al (2004). nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulation myosin light chain phosphorylation. Int J Cancer, 108, 207-11.